Use of full-length amelogenin for promoting nerve growth or regeneration
AssigneesHadasit Medical Research Services and Development Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem
InventorsAmir Haze, Anat Blumenfeld, Dan Deutsch
Life of this patent
Estimating the term…
Abstract
A method of promoting nerve growth or regeneration in a subject in need thereof, wherein the subject is not afflicted with a substantial connective tissue damage, is provided. The method comprises administering to the subject a therapeutically effective amount of full-length amelogenin, thereby promoting nerve growth or regeneration in the subject.
Claims21
A method of promoting nerve growth or regeneration in a subject in need thereof, the method comprising directly administering to an injured nerve of the subject a therapeutically effective amount of full-length amelogenin, thereby promoting nerve growth or regeneration in the subject, wherein said injured nerve is a peripheral or a spinal cord nerve.
Dependencies are inferred from the claim text.